Oak Ridge Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,648
Closed -$980K 186
2025
Q4
$980K Sell
9,648
-577
-6% -$46.3K 0.06% 127
2025
Q3
$559K Buy
10,225
+24
+0.2% +$1.2K 0.04% 146
2025
Q2
$542K Buy
10,201
+36
+0.4% +$1.83K 0.04% 142
2025
Q1
$440K Sell
10,165
-245
-2% -$12.4K 0.04% 142
2024
Q4
$585K Buy
10,410
+10
+0.1% +$622 0.05% 144
2024
Q3
$708K Sell
10,400
-235
-2% -$13.3K 0.06% 127
2024
Q2
$449K Buy
10,635
+2,088
+24% +$115K 0.04% 138
2024
Q1
$590K Sell
8,547
-996
-10% -$63K 0.06% 132
2023
Q4
$706K Sell
9,543
-561
-6% -$36.8K 0.08% 131
2023
Q3
$689K Buy
+10,104
New +$857K 0.09% 128
2020
Q1
Sell
-5,033
Closed -$465K 175
2019
Q4
$465K Sell
5,033
-437
-8% -$38.4K 0.03% 168
2019
Q3
$494K Buy
+5,470
New +$623K 0.04% 162

Other funds holding EXAS

Oak Ridge Investments's EXAS Position: Q1 2026 in Review

Oak Ridge Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,648 shares — an estimated $980K sold.

Oak Ridge Investments first reported a position in EXAS in Q3 2019 and held it in 12 quarters. The position peaked at $980K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Oak Ridge Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Oak Ridge Investments sold 9,648 Exact Sciences shares in Q1 2026, an estimated $980K.
  • Oak Ridge Investments first reported a position in Exact Sciences in Q3 2019 and held it in 12 quarters.
  • Oak Ridge Investments's Exact Sciences position peaked at $980K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Oak Ridge Investments's 13F filing for Q1 2026, filed 30 Apr 2026.